AMSTERDAM, April 21, 2022 (GLOBE NEWSWIRE) Xinvento, a biotech company aiming to improve the lives of those with Congenital Hyperinsulinism, announces today the completion of a seed funding round. The
Dutch Biotech Xinvento Raises Seed Round to Develop Treatment for Congenital Hyperinsulinism globalgenes.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globalgenes.org Daily Mail and Mail on Sunday newspapers.
ProQR Restructures, Cuts Workforce and Select Rare Disease Programs globalgenes.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globalgenes.org Daily Mail and Mail on Sunday newspapers.
ProQR Appoints John Maraganore as Strategic Advisor to the Supervisory Board globalgenes.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globalgenes.org Daily Mail and Mail on Sunday newspapers.